Voyager Therapeutics, Inc. (VYGR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 230.66M |
| Enterprise Value | 201.86M |
| P/E Ratio | -1.01 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 4.36 |
| Price/Book Ratio | 0.81 |
| Enterprise/Revenue | 3.65 |
| Enterprise/EBITDA | -0.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -4.16 |
| Operating Margin | -4.5 |
| Return On Assets | -0.59 |
| Return On Equity | -0.63 |
| Revenue | 40.37M |
| Revenue/Share | 0.41 |
| Gross Profit | -91.9M |
| EBITDA | -115.52M |
| Net Income | -119.72M |
| Diluted EPS | -2.04 |
| Total Cash | 106.81M |
| Total Cash/Share | 1.73 |
| Total Debt | 30.51M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 6.81 |
| Book Value Per Share | 2.19 |
| 52-Week Change | -58.69 |
| 52-Week High | 5.48 |
| 52-Week Low | 1.68 |
| Moving Average 50 Days | 2.48 |
| Moving Average 200 Days | 3.39 |
| Average Volume | 728,575 |
| Shares Outstanding | 62.23M |
| % Held by Institutions | 58.15 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |